Skip to main content
. 2024 Mar 7;16(6):1080. doi: 10.3390/cancers16061080

Figure 1.

Figure 1

Overall survival curves in the training (T) and validation (V) groups according to the presence of sarcopenia (a) or MELD > 9 (b).